Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.5 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.1 | 0.5 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.035 | 0.5 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |